Correlation Between PureTech Health and DG Innovate

Can any of the company-specific risk be diversified away by investing in both PureTech Health and DG Innovate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PureTech Health and DG Innovate into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PureTech Health plc and DG Innovate PLC, you can compare the effects of market volatilities on PureTech Health and DG Innovate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PureTech Health with a short position of DG Innovate. Check out your portfolio center. Please also check ongoing floating volatility patterns of PureTech Health and DG Innovate.

Diversification Opportunities for PureTech Health and DG Innovate

0.31

Correlation Coefficient

PureTech Health  DG Innovate

Weak diversification

The 3 months correlation between PureTech and DGI is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding PureTech Health plc and DG Innovate PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DG Innovate PLC and PureTech Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PureTech Health plc are associated (or correlated) with DG Innovate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DG Innovate PLC has no effect on the direction of PureTech Health i.e., PureTech Health and DG Innovate go up and down completely randomly.

Pair Corralation between PureTech Health and DG Innovate

Assuming the 90 days trading horizon PureTech Health is expected to generate 5.21 times less return on investment than DG Innovate. But when comparing it to its historical volatility, PureTech Health plc is 3.08 times less risky than DG Innovate. It trades about 0.08 of its potential returns per unit of risk. DG Innovate PLC is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  7.10  in DG Innovate PLC on September 5, 2024 and sell it today you would earn a total of  1.40  from holding DG Innovate PLC or generate 19.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

PureTech Health plc  vs.  DG Innovate PLC

PureTech Health plc

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in PureTech Health plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, PureTech Health may actually be approaching a critical reversion point that can send shares even higher in January 2025.

DG Innovate PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days DG Innovate PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, DG Innovate is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with PureTech Health and DG Innovate

The main advantage of trading using opposite PureTech Health and DG Innovate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PureTech Health position performs unexpectedly, DG Innovate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DG Innovate will offset losses from the drop in DG Innovate's long position.

The idea behind PureTech Health plc and DG Innovate PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.